2026-526083-20-00RecruitingPhase 1
A research study looking into how a high dose of s.c. semaglutide works with emptying of the stomach in people with excess body weight
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 60
- Locations
- 1
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
EU Submission Hub
Scientific
Novo Nordisk A/S
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Effect of different doses of shockwave therapy on pain and function in adults with chronic non-specific low back pain.Chronic Non-Specific Low Back PainMusculoskeletal - Other muscular and skeletal disordersACTRN12626000978369LINCOLN UNIVERSITY COLLEGE, MALAYSIA120
Recruiting
Phase 1
A research study looking into how a single dose of the medicine NNC0537-1482 moves through the body of participants with normal or reduced kidney functionHeart failure with preserved ejection fraction2026-525271-57-00Novo Nordisk A/S54
Recruiting
Phase 1
A study to see how a single increasing dose of the oral drug AD-700 affects the ability of a CT scan to detect activated brown fat in healthy people2025-520584-41-00Adiposs S.A.18
Recruiting
Phase 1
A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A2025-520490-38-00Novo Nordisk A/S16
Recruiting
Phase 1
A study to investigate how a single dose of the drug melflufen reaches brain tumor tissue, and how it affects the tumour, in patients who are already scheduled for surgery for a returning glioblastomaRecurrent glioblastoma2026-525543-32-00Oncopeptides AB10